AIS
ALDX icon

AlphaOne Investment Services’s Aldeyra Therapeutics ALDX Stock Holding History

AlphaOne Investment Services’s Portfolio ALDX Stock Details ALDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-2,375
Closed -$16K – 456
2017
Q4 		$16K Buy
2,375
+1,650
+228% +$10.9K ﹤0.01% 283
2017
Q3 		$5K Buy
+725
New +$3.79K ﹤0.01% 287

Other funds holding ALDX

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
HP
Hikari Power Tokyo, Japan $1.15B AUM 5.31% 1-Year Est. Return

AlphaOne Investment Services's ALDX Position: Q1 2018 in Review

AlphaOne Investment Services sold out of Aldeyra Therapeutics (ALDX) in Q1 2018, closing a stake of 2,375 shares — an estimated $16K sold.

AlphaOne Investment Services first reported a position in ALDX in Q3 2017 and held it in 2 quarters. The position peaked at $16K in Q4 2017. 45 funds tracked by Wall St. Rank hold ALDX as of Q1 2018.

  • AlphaOne Investment Services reported no remaining Aldeyra Therapeutics position as of Q1 2018 after selling out during the quarter.
  • AlphaOne Investment Services sold 2,375 Aldeyra Therapeutics shares in Q1 2018, an estimated $16K.
  • AlphaOne Investment Services first reported a position in Aldeyra Therapeutics in Q3 2017 and held it in 2 quarters.
  • AlphaOne Investment Services's Aldeyra Therapeutics position peaked at $16K in Q4 2017.
  • 45 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q1 2018.

Based on AlphaOne Investment Services's 13F filing for Q1 2018, filed 14 May 2018.